SIYA-PT: An Internet-based CBT Intervention to Enhance Low Self-esteem Among Portuguese Emerging Adults
SIYA-PT: An Internet-based CBT Intervention to Enhance Low Self-esteem
This study investigates whether an eHealth cognitive-behavioural therapy (CBT) intervention for low self-esteem, SIYA-PT, is acceptable and feasible for an ethnically diverse population of emerging adults in Portugal.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
Low self-esteem (LSE) is a negative cognitive representation of the self, based on personal experience, and it influences how information is processed.
LSE has been linked to worse psychological adjustment, and research has found that CBT-based interventions using Fennell's cognitive model of low self-esteem were able to improve participants' self-esteem.
SIYA-PT is a cultural adaptation of SIYA, a guided internet-based CBT intervention developed for Swedish adolescents, and it is based on Cognitive Model of Low Self-Esteem, Self-Determination Theory, and Self-Compassion Theory. SIYA-PT has 7 modules that will be presented to participants, one module per week.
The investigators aim to evaluate whether a culturally adapted iCBT intervention is accepted by Portuguese emerging adults - people aged 18 to 29 years old - and whether it is feasible in enhancing self-esteem and improving anxiety and depressive symptoms and quality of life.
This study is a pilot-randomised controlled trial. The study will have an intervention group (IG) that will receive the intervention (SIYA-PT) immediately after randomisation, and a waitlist control group (WCG) that will receive the intervention after follow-up, 3 months after IG finishes their intervention.
The investigators aim to recruit at least 58 participants with LSE, considering a 31% dropout.
The main outcomes of the study are self-esteem, quality of life and anxiety and depressive symptoms and the secondary outcomes are self-compassion and assertiveness.
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Ivanilda B. Costa, MSc
- Número de telefone: +351920086596
- E-mail: siya.pt.project@gmail.com
Locais de estudo
-
-
Lisbon District
-
Lisbon, Lisbon District, Portugal
- Ivanilda B. Costa
-
Contato:
- Ivanilda B. Costa, MSc
- Número de telefone: +351920086596
- E-mail: siya.pt.project@gmail.com
-
Contato:
- Patrícia M. Pascoal, PhD
- E-mail: patricia.pascoal@ulusofona.pt
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Scores of ≤15 on the Rosenberg Self-esteem Scale and <120 on the Robson Self-concept Questionnaire indicating low self-esteem;
- Scores of ≤ 50 on the WHOQOL-BREF indicating low quality of life
- Age between 18 and 29 years old
- Fluency in written and spoken Portuguese
- Daily access to a device with an internet connection
- Not receiving any psychological intervention
- If on psychopharmacological treatment, must be in treatment for at least three months and the dosage must be stable for at least one month
- Residence in Portugal
Exclusion Criteria:
- Severe psychiatric disorders such as Depressive Disorder or Suicidal ideation, which will be self-reported on the Sociodemographic Questionnaire and assessed through a Structured Interview developed by the research team
- Alcohol Use Disorder, which will be assessed using the Alcohol Use Disorder Identification Test
- Personal relationship with PHD student (e.g., former patients or students, friends, family members)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: Intervention Group (IG)
IG will have access to the intervention (SIYA-PT). The participants will have an individual login to use the platform, and have access to the modules and the measures that need to be filled out throughout the study. |
SIYA-PT has seven modules: Module 1 - Introduction Module 2 - Achievements and self-esteem Module 3 - Relationships and self-esteem Module 4 - Independence and self-esteem Module 5 - Dealing with adversities Module 6 - Self-acceptance Module 7 - Termination and continuation |
|
Outro: Waitlist Control Group (WCG)
WCG will not receive the intervention while IG goes through SIYA-PT. The participants will have an individual login to access the platform to answer the self-reported measures weekly to monitor their well-being. The participants will also have access to messaging to be able to contact the clinical psychologist on the platform if there is increase in their, e.g., anxiety and depressive symptoms. After the end of IG intervention and the follow-up , three months, WCG will receive the same SIYA-PT intervention. |
SIYA-PT has seven modules: Module 1 - Introduction Module 2 - Achievements and self-esteem Module 3 - Relationships and self-esteem Module 4 - Independence and self-esteem Module 5 - Dealing with adversities Module 6 - Self-acceptance Module 7 - Termination and continuation |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
The Rosenberg Self-esteem Scale (RSE)
Prazo: Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
A 10-item self-report measure to assess global self-esteem. The RSE (Rosenberg, 1965; Pechorro et al., 2011) uses a 4-point Likert scale to rate agreement with the statements, from 0 (Strongly disagree) to 3 (Strongly agree). Scores vary from 0 to 30, with higher scores indicating higher levels of global self-esteem. |
Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
|
Robson Self-Concept Questionnaire (RSCQ)
Prazo: Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
A 30-item self-report measure to assess global self-esteem. The RSCQ (Robson, 1989) uses a 7-point Likert scale to rate agreement with each statement, from 0 (Completely disagree) to 7 (Completely agree). Scores vary from 0 to 210, with higher scores indicating higher levels of global self-esteem. |
Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
|
Generalised Anxiety Disorder 7-item Scale (GAD-7)
Prazo: Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
A seven-item self-report measure to assess generalised anxiety disorder according to DSM-IV criteria. GAD-7 (Spitzer et al., 2006; Sousa et al., 2015) uses a 4-point Likert scale to rate how often one has experienced the described situation, from 0 (Never) to 3 (Almost every day). Scores vary from 0 to 21, with higher scores indicating higher levels of anxiety. |
Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
|
Patient Health Questionnaire 9-item (PHQ-9)
Prazo: Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
A nine-item self-report measure to assess depressive symptoms according to DSM-IV criteria. PHQ-9 (Kroenke et al., 2001; Lamela et al., 2020) uses a 4-point Likert scale to rate how often one has experienced the described situation, from 0 (Never) to 3 (Almost every day). Scores vary from 0 to 27, with higher scores indicating higher levels of depressive symptoms. |
Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
|
WHOQOL-BREF
Prazo: Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
A 26-item self-report measure with four domains (physical health, psychological health, social relationships and environment) to assess perceived quality of life. WHOQOL-BREF (The WHOQOL Group, 1998; Vaz Serra et al., 2006) uses a 5-point Likert scale, from 1 ("Very Poor", "Not at all" or "Very dissatisfied") to 5 ("Very good", "Completely", "Always" or "Very satisfied") to ask how one feels about their quality of life, health, or other areas of their life. Scores vary from 0 to 100, with higher scores indicating higher perceived quality of life. |
Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Self-Compassion Scale (SCS)
Prazo: Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
A 26-item self-report measure with six subscales (Self-Kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification) that assesses how one typically responds in difficult times in terms of self-compassion. SCS (Neff, 2003; Castilho & Pinto-Gouveia, 2015) uses a 5-point Likert scale to rate how often one does each behaviour described in each item, from 1 (Almost never) to 5 (Almost always). Higher scores indicate higher levels of self-compassion. |
Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
|
The Rathus Assertiveness Schedule (RAS)
Prazo: Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
A 30-item self-report measure to assess assertive behaviour. RAS (Rathus, 1973; Detry & Castro, 1990) uses a 6-point Likert scale to rate how well each item describes the person, from 5 (Very much like me) to 0 (Very much unlike me). Scores vary from 0 to 30, with higher scores indicating higher assertiveness. |
Pre-intervention (baseline), post-intervention (up to 8 weeks), and at the three-month follow-up
|
Outras medidas de resultado
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Alcohol Use Disorder Identification Test (AUDIT)
Prazo: pre-intervention (baseline)
|
A 10-item self-report measure to screen for three areas (alcohol consumption, dependence symptoms and alcohol-related problems) of alcohol-use-related problems using a 5-point Likert scale. AUDIT (WHO, 1989) scores vary from 0 to 40, from 0 to 4, with higher scores indicating higher levels of alcohol-use-related problems. |
pre-intervention (baseline)
|
|
Structure interview
Prazo: pre-intervention (baseline)
|
An interview guide with 14 questions developed by the research team based on questions from Mini International Neuropsychiatric Interview (Sheehan et al., 1998)'s subscale for Suicide Ideation and DSM-5-TR criteria for Major Depressive Disorder with a dichotomous answer - No or Yes. |
pre-intervention (baseline)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Publicações e links úteis
Publicações Gerais
- Neff KD. Self-Compassion: Theory, Method, Research, and Intervention. Annu Rev Psychol. 2023 Jan 18;74:193-218. doi: 10.1146/annurev-psych-032420-031047. Epub 2022 Aug 12.
- Deci, E. L., & Ryan, R. M. (2000). The" what" and" why" of goal pursuits: Human needs and the self-determination of behavior. Psychological Inquiry, 11(4), 227-268. https://doi.org/10.1207/S15327965PLI1104_01
- Fennell, M. J. V. (1997). Low self-esteem: A cognitive perspective. Behavioural and Cognitive Psychotherapy, 25(1), 1-25. https://doi.org/10.1017/S1352465800015368
- Berg M, Lindegaard T, Flygare A, Sjobrink J, Hagvall L, Palmeback S, Klemetz H, Ludvigsson M, Andersson G. Internet-based CBT for adolescents with low self-esteem: a pilot randomized controlled trial. Cogn Behav Ther. 2022 Sep;51(5):388-407. doi: 10.1080/16506073.2022.2060856. Epub 2022 May 3.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
Outros números de identificação do estudo
- 2024.00914.BD
- 2024.00914.BD (Número de outro subsídio/financiamento: Fundação para a Ciência e a Tecnologia)
- https://doi.org/10.54499/2024. (Outro identificador: Fundação para a Ciência e a Tecnologia)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Study participants have not given consent for their individual data to be shared with other researchers.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .